Total Flavonoids of Propolis dropping pill
DrugOne pack contains 30 pills, weight 33g. One pack each time, three times a day, 14 days a course.
NCT Number: NCT01453582
The purpose of this study is to confirm the efficacy and safety of total flavonoids of propolis dropping pill to treat angina pectoris, evaluated by total exercise time of treadmill exercise test.
Looking for future studies?
Notify Me35 year–70 year
All sexes
Interventional
Phase 3
Guangdong Second Provincial Traditional Chinese Medicine Hospital, Guangzhou, Guangdong, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One pack contains 30 pills, weight 33g. One pack each time, three times a day, 14 days a course.
Time frame: -2 week, 0 weeks, 12 weeks
Time frame: -2 weeks, 0 week, 6 weeks, 12 weeks
Time frame: -2 weeks, 0 week, 6 weeks, 12 weeks
Time frame: -2 weeks, 0 week, 12 weeks
Time frame: -2 weeks, 0 week, 6 weeks, 12 weeks
Time frame: -2 weeks, 0 week, 6 weeks, 12 weeks
Time frame: -2 weeks, 0 week, 6 weeks, 12 weeks
Effect index = (total score before treatment - total score after treatment)/total score before treatment×100%
Time frame: 0 week, 12 weeks
Time frame: -2 weeks, 0 week, 12 weeks
Time frame: -2 weeks, 0 week, 12 weeks
metabolic equivalent, blood pressure, oxygen consumption, speed, grade.
Time frame: -2 weeks, 0 week, 12 weeks
Shanghai Greenvalley Pharmaceutical Co., Ltd.
Industry
Phase III Study of Total Flavonoids of Propolis Dropping Pill in Angina Pectoris: A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Clinical Trial on Efficacy and Safety.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04465669
Angina Pectoris, Angina, Stable
Tyumen, Russia
View Trial DetailsNCT04938661
Acute Coronary Syndrome, Acute Myocardial Infarction
Minneapolis, Minnesota, United States
View Trial DetailsNCT07378228
Angina Pectoris, Angina, Stable
Harbin, Heilongjiang, China
View Trial DetailsNCT03341663
Acupoint Sensitization, Angina Pectoris
Chengdu, Sichuan, China
View Trial Details